ICDM's ASEAN Board Trends 2026/2027 imperatives critical for future readiness as technology, sustainability and business transformation reshape the governance landscape
ASEAN boards are at a...
HighTide Therapeutics, Inc. (HKG: 02511), an innovative biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapies for cardiovascular–kidney–metabolic (CKM) diseases, today...